IBA deploys proton therapy in Tennessee
ProVision Trust and the Proton Therapy Center have selected IBA and made a down payment for the installation of a proton therapy facility in Knoxville, Tenn.
The project includes the supply and installation of a proton therapy facility consisting of two isocentric gantry treatment rooms, a fixed-beam treatment room and a research room, said the Louvain-la-Neuve, Belgium-based company. In addition, IBA will provide operation and maintenance services for a period of 10 years. The contract represents total revenues of $70 to $80 million for IBA over the term of the agreement.
The center’s primary clinical partners will be the University of Tennessee Medical Center, the East Tennessee Children’s Hospital, Tennessee Cancer Specialists and the Knoxville Comprehensive Breast Center.
The project includes the supply and installation of a proton therapy facility consisting of two isocentric gantry treatment rooms, a fixed-beam treatment room and a research room, said the Louvain-la-Neuve, Belgium-based company. In addition, IBA will provide operation and maintenance services for a period of 10 years. The contract represents total revenues of $70 to $80 million for IBA over the term of the agreement.
The center’s primary clinical partners will be the University of Tennessee Medical Center, the East Tennessee Children’s Hospital, Tennessee Cancer Specialists and the Knoxville Comprehensive Breast Center.